V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019488 | 220007766 | 1.52 | 0 | Disease modification (D) | 2017-08-28 | 2017-10-11 | IDARUBICIN + TRETINOIN | 2 | N | 220029889 | IDARUBICIN + TRETINOIN |
| 220019489 | 220021531 | 1.68 | 113.8 | Curative (C) | 2018-10-01 | 2018-10-01 | ATG + Busulfan + Fludarabine | N | null | 220029900 | ATG + BUSULFAN + FLUDARABINE |
| 220019490 | 220007770 | null | 52.5 | Curative (C) | 2018-08-13 | 2018-08-23 | IDARUBICIN + TRETINOIN | N | N | 220029903 | IDARUBICIN + TRETINOIN |
| 220019491 | 220007772 | 1.76 | 60 | Disease modification (D) | 2013-10-06 | 2013-12-21 | Cyclophosphamide+Fludara+TBI Allo | 2 | N | 220029906 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019492 | 220007776 | 1.67 | 60 | Curative (C) | 2018-01-25 | 2018-01-25 | Methotrexate intrathecal | 02 | null | 220029943 | METHOTREXATE INTRATHECAL |
| 220019493 | 220007783 | null | null | Curative (C) | 2014-08-27 | 2014-08-27 | ATG + Busulfan + Fludarabine | null | N | 220029966 | ATG + BUSULFAN + FLUDARABINE |
| 220019494 | 220007789 | 1.84 | 71.8 | Curative (C) | 2014-08-21 | 2014-11-30 | Idarubicin+Tretinoin Spanish Crse4 | N | N | 220029989 | IDARUBICIN + TRETINOIN |
| 220019495 | 220007793 | 1.68 | 55.1 | Curative (C) | 2015-09-04 | 2015-09-20 | FLAG | N | N | 220029995 | FLAG |
| 220019496 | 220007794 | null | 72.5 | Curative (C) | null | 2017-11-06 | ATG + Busulfan + Fludarabine | null | N | 220030009 | ATG + BUSULFAN + FLUDARABINE |
| 220019497 | 220007795 | 1.59 | 0 | Curative (C) | 2017-04-24 | 2017-04-24 | FLAG | Y | N | 220030022 | FLAG |
| 220019498 | 220007798 | null | null | Curative (C) | 2016-06-20 | 2016-08-28 | Triple Intrathecal | N | null | 220030037 | TRIPLE INTRATHECAL |
| 220019499 | 220007804 | 1.76 | 107.5 | Curative (C) | 2017-05-22 | 2017-05-22 | Methotrexate intrathecal | N | N | 220030047 | METHOTREXATE INTRATHECAL |
| 220019500 | 220014300 | 1.65 | 68.8 | Curative (C) | 2018-01-02 | 2018-02-13 | Idarubicin+Tretinoin Spanish Crse1 | 02 | Y | 220030066 | IDARUBICIN + TRETINOIN |
| 220019501 | 220007819 | 1.6 | 66 | Curative (C) | 2016-08-09 | 2016-10-31 | AML16 DA 3+10 | N | N | 220030073 | AML16 TRIAL |
| 220019502 | 220017804 | 1.52 | null | Not known (9) | 2017-04-19 | 2017-05-29 | AML Int Guide ADE 8+3+5 (2) | N | N | 220030089 | ADE |
| 220019503 | 220014305 | 1.63 | 89.6 | Disease modification (D) | null | 2016-08-04 | IDARUBICIN + TRETINOIN | null | N | 220030092 | IDARUBICIN + TRETINOIN |
| 220019504 | 220007825 | 1.57 | 61.35 | Curative (C) | 2013-10-11 | 2013-12-01 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 220030099 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019505 | 220007828 | 1.66 | 102 | Disease modification (D) | 2014-02-25 | 2014-03-23 | Methotrexate intrathecal | N | N | 220030109 | METHOTREXATE INTRATHECAL |
| 220019506 | 220014309 | 1.41 | null | Curative (C) | 2016-02-01 | 2016-02-01 | IDARUBICIN + TRETINOIN | N | null | 220030109 | IDARUBICIN + TRETINOIN |
| 220019507 | 220014310 | 1.65 | null | Curative (C) | 2016-03-10 | 2016-05-03 | CYCLOPHOSPHAMIDE | 2 | N | 220030114 | CYCLOPHOSPHAMIDE |
| 220019508 | 220007833 | 1.8 | 82 | Disease modification (D) | 2014-03-31 | 2014-04-13 | BOSUTINIB | N | N | 220030138 | BOSUTINIB |
| 220019509 | 220014314 | null | 71 | Curative (C) | 2015-05-13 | 2015-10-05 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220030142 | IDARUBICIN + TRETINOIN |
| 220019510 | 220007838 | 1.71 | 65 | Curative (C) | 2015-11-14 | 2015-11-24 | Methotrexate intrathecal | N | N | 220030144 | METHOTREXATE INTRATHECAL |
| 220019511 | 220007842 | 1.7 | 22.3 | Curative (C) | 2014-03-13 | 2014-03-13 | IDARUBICIN + TRETINOIN | N | N | 220030145 | IDARUBICIN + TRETINOIN |
| 220019512 | 220007845 | 0 | 67.8 | Curative (C) | null | 2018-08-10 | BOSUTINIB | 2 | N | 220030148 | BOSUTINIB |
| 220019513 | 220007852 | 1.64 | 65 | Disease modification (D) | 2019-01-24 | 2019-01-24 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 220030168 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019514 | 220007857 | 1.8 | 107.7 | Curative (C) | 2017-01-17 | 2017-01-18 | ATG + Busulfan + Fludarabine | 2 | N | 220030182 | ATG + BUSULFAN + FLUDARABINE |
| 220019515 | 220007861 | 1.7 | 72 | Curative (C) | 2017-11-27 | 2018-04-30 | Cyclophosphamide TBI Allograft | Y | N | 220030188 | CYCLOPHOSPHAMIDE |
| 220019516 | 220007874 | 1.74 | 62.95 | Curative (C) | 2017-05-11 | 2017-05-18 | Cyclophosphamide TBI Allograft | N | N | 220030225 | CYCLOPHOSPHAMIDE |
| 220019517 | 220007879 | null | 71.6 | Curative (C) | 2017-03-13 | 2017-03-13 | AML16 DA 3+10 | N | N | 220030233 | AML16 TRIAL |
| 220019518 | 220007885 | 1.54 | 74.1 | Curative (C) | 2015-11-26 | 2016-01-30 | Cyclophosphamide TBI Allograft | N | N | 220030250 | CYCLOPHOSPHAMIDE |
| 220019520 | 220007893 | 1.58 | null | Adjuvant (A) | 2017-06-05 | 2017-06-05 | FLAG | 02 | N | 220030275 | FLAG |
| 220019521 | 220007903 | 1.64 | 66.5 | Curative (C) | 2014-11-19 | 2016-08-08 | AML16 Low Dose Cytarabine | 02 | N | 220030293 | AML16 TRIAL |
| 220019522 | 220014336 | 1.72 | 95 | Disease modification (D) | 2014-10-20 | 2014-10-21 | RUXOLITINIB | N | N | 220030293 | RUXOLITINIB |
| 220019523 | 220007905 | null | null | Disease modification (D) | 2017-05-12 | 2017-05-12 | AML16 DA 3+8 | 2 | N | 220030299 | AML16 TRIAL |
| 220019524 | 220007909 | 1.58 | 46.9 | Curative (C) | 2014-07-15 | 2014-07-17 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | null | 220030302 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019525 | 220014341 | 1.59 | 59 | Curative (C) | null | 2017-04-12 | ATG + Busulfan + Fludarabine | N | N | 220030310 | ATG + BUSULFAN + FLUDARABINE |
| 220019526 | 220007915 | 1.8 | 102.6 | Disease modification (D) | null | 2015-05-24 | Idarubicin+Tretinoin Spanish Crse4 | 02 | N | 220030316 | IDARUBICIN + TRETINOIN |
| 220019527 | 220021537 | 1.57 | 75 | Curative (C) | 2015-02-07 | 2015-05-19 | Idarubicin+Tretinoin Spanish Crse4 | N | N | 220030337 | IDARUBICIN + TRETINOIN |
| 220019528 | 220007926 | null | 82 | Curative (C) | 2014-02-01 | 2014-02-01 | AML16 DA 3+8 | 02 | N | 220030339 | AML16 TRIAL |
| 220019529 | 220007929 | 1.83 | 81.4 | Curative (C) | 2013-04-19 | 2014-01-01 | AML16 DA 2+5 | N | N | 220030353 | AML16 TRIAL |
| 220019530 | 220007937 | 1.78 | 71.8 | Curative (C) | 2015-05-21 | 2015-05-21 | FLAG | N | N | 220030383 | FLAG |
| 220019531 | 220014353 | 1.33 | 74.1 | Curative (C) | 2015-05-26 | 2015-05-26 | ATG + Busulfan + Fludarabine | 02 | null | 220030395 | ATG + BUSULFAN + FLUDARABINE |
| 220019532 | 220017832 | 1.72 | 80.7 | Curative (C) | 2014-03-18 | 2014-03-18 | AML16 DA 3+8 | Y | N | 220030429 | AML16 TRIAL |
| 220019533 | 220007944 | 1.7 | null | Curative (C) | 2016-09-28 | 2016-11-17 | ATG + Busulfan + Fludarabine | null | N | 220030431 | ATG + BUSULFAN + FLUDARABINE |
| 220019534 | 220017833 | 1.73 | 107.7 | Palliative (P) | null | 2017-11-26 | AML Int Guide ADE 8+3+5 (2) | N | null | 220030435 | ADE |
| 220019535 | 220007956 | 1.74 | 71 | Curative (C) | 2017-05-11 | 2017-05-13 | Triple Intrathecal | Y | N | 220030458 | TRIPLE INTRATHECAL |
| 220019536 | 220007959 | 0 | 106.8 | Curative (C) | 2014-06-21 | 2014-07-05 | FLAG | 01 | N | 220030466 | FLAG |
| 220019537 | 220007959 | 0 | 68.4 | Curative (C) | 2015-03-22 | 2015-03-22 | Idarubicin+Tretinoin Spanish Crse2 | 02 | N | 220030466 | IDARUBICIN + TRETINOIN |
| 220019538 | 220007963 | 1.7 | 60.5 | Curative (C) | 2018-06-28 | 2018-07-14 | BOSUTINIB | 02 | N | 220030475 | BOSUTINIB |